跳至主要内容
临床试验/NCT04332393
NCT04332393已完成4 期

The Effect of Metformin in Pregnant Women Who Received Antenatal Corticosteroids on Glycemic Control and the Rate of Neonatal Hypoglycemia - Multicenter Prospective Randomized, Controlled Trial

The Baruch Padeh Medical Center, Poriya4 个研究点 分布在 1 个国家目标入组 187 人开始时间: 2020年7月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
187
试验地点
4
主要终点
The rate of neonatal hypoglycemia in preterm deliveries (<37 gestational weeks)

研究概览

简要总结

Antenatal corticosteroids, particularly, betamethasone is routinely administered to pregnant women at risk for preterm delivery to improve neonatal outcomes.

Although antenatal betamethasone was shown to induce both maternal hyperglycemia and neonatal hypoglycemia, to date, there is insufficient data to establish whether treatment for maternal hyperglycemia, particularly, metformin, will decrease the risk for neonatal hypoglycemia, particularly of preterm neonates.

In the present study the investigators will examine the effect of treatment with metformin on maternal glycemic control and hypoglycemia in preterm neonates following maternal betamethasone treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women receiving betamethasone from 24 to 36.5 gestational weeks
  • Before or within 24 hours following the first dose of betamethasone
  • ≥18 years old

排除标准

  • Women with pre-gestational and gestational diabetes mellitus (GDM)
  • Known allergic sensitivity to metformin
  • Known chronic heart failure
  • Known chronic renal failure
  • Refuse to participate
  • Refuse to perform glucose challenge test/glucose tolerance test later on

研究组 & 干预措施

metformin group

Experimental

干预措施: Metformin (Drug)

结局指标

主要结局

The rate of neonatal hypoglycemia in preterm deliveries (<37 gestational weeks)

时间窗: Up to 7 days after delivery or discharge (which ever comes first)

Mean maternal daily glucose values

时间窗: Up to 4 days

According to daily glucose charts

次要结局

  • Mean maternal daily post-prandial glucose values(Up to 4 days)
  • Percent of abnormal values in the daily glucose chart(Up to 4 days)
  • Rate of neonates who will be admitted to the neonatal intensive care unit(Up to a week after delivery)
  • Apgar score at 1 and 5 minutes(At delivery)
  • Rate of cesarean sections and operative deliveries(At delivery)
  • Mean maternal daily pre-prandial glucose values(Up to 4 days)
  • Mean and lowest neonatal blood glucose values in preterm neonates(Up to 7 days after delivery or discharge (which ever comes first))
  • Cord blood pH levels (when taken)(At delivery)
  • The rate of neonates with hyperbilirubinemia(Up to 7 days after delivery or discharge (which ever comes first))
  • Neonatal mean birth weight(at delivery)
  • Neonatal mean head circumference(Up to 7 days after delivery or discharge (which ever comes first))
  • The rate of fetal malformations and developmental disorders(Up to 7 days after delivery or discharge (which ever comes first))
  • The rate of maternal adverse effects(48 hours)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验